Suppr超能文献

相似文献

1
Polygenic hazard score is associated with prostate cancer in multi-ethnic populations.
Nat Commun. 2021 Feb 23;12(1):1236. doi: 10.1038/s41467-021-21287-0.
4
Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score.
Prostate Cancer Prostatic Dis. 2022 Apr;25(4):755-761. doi: 10.1038/s41391-022-00497-7. Epub 2022 Feb 12.
5
Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry.
Am J Hum Genet. 2023 Jul 6;110(7):1200-1206. doi: 10.1016/j.ajhg.2023.05.010. Epub 2023 Jun 12.
6
A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data.
Cancer Epidemiol Biomarkers Prev. 2020 Sep;29(9):1731-1738. doi: 10.1158/1055-9965.EPI-19-1527. Epub 2020 Jun 24.
7
Polygenic Risk Score and Upgrading in Patients With Prostate Cancer Receiving Active Surveillance.
JAMA Oncol. 2025 Feb 1;11(2):168-171. doi: 10.1001/jamaoncol.2024.5398.
8
African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer.
Int J Cancer. 2021 Jan 1;148(1):99-105. doi: 10.1002/ijc.33282. Epub 2020 Sep 24.
9
Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
JAMA Netw Open. 2022 Jan 4;5(1):e2144027. doi: 10.1001/jamanetworkopen.2021.44027.
10
Association among plasma 1,25(OH) D, ratio of 1,25(OH) D to 25(OH)D, and prostate cancer aggressiveness.
Prostate. 2019 Jul;79(10):1117-1124. doi: 10.1002/pros.23824. Epub 2019 May 11.

引用本文的文献

1
Polygenic risk scores for prostate cancer: Comparative evaluations in UK and Australian cohorts.
HGG Adv. 2025 Jul 7;6(4):100477. doi: 10.1016/j.xhgg.2025.100477.
2
Deficits of Molecular Prognosis/Diagnosis Studies in Underserved Populations.
JCO Oncol Pract. 2024 Nov;20(11):1515-1522. doi: 10.1200/OP.24.00131. Epub 2024 Nov 12.
4
Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective Cohort.
Cancer Epidemiol Biomarkers Prev. 2024 Nov 1;33(11):1500-1511. doi: 10.1158/1055-9965.EPI-24-0326.
5
Racial disparity in prostate cancer: an outlook in genetic and molecular landscape.
Cancer Metastasis Rev. 2024 Dec;43(4):1233-1255. doi: 10.1007/s10555-024-10193-8. Epub 2024 Jun 20.
6
Integration of polygenic and gut metagenomic risk prediction for common diseases.
Nat Aging. 2024 Apr;4(4):584-594. doi: 10.1038/s43587-024-00590-7. Epub 2024 Mar 25.
8
Ethnic differences in prostate cancer presentation: a time for testing advocacy.
World J Urol. 2023 Dec;41(12):3543-3549. doi: 10.1007/s00345-023-04644-0. Epub 2023 Oct 11.
9
Polygenic risk scores: the future of cancer risk prediction, screening, and precision prevention.
Med Rev (2021). 2022 Feb 14;1(2):129-149. doi: 10.1515/mr-2021-0025. eCollection 2021 Dec.
10
Racial disparity in the genomics of precision oncology of prostate cancer.
Cancer Rep (Hoboken). 2023 Sep;6 Suppl 1(Suppl 1):e1867. doi: 10.1002/cnr2.1867. Epub 2023 Aug 10.

本文引用的文献

1
African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer.
Int J Cancer. 2021 Jan 1;148(1):99-105. doi: 10.1002/ijc.33282. Epub 2020 Sep 24.
2
A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data.
Cancer Epidemiol Biomarkers Prev. 2020 Sep;29(9):1731-1738. doi: 10.1158/1055-9965.EPI-19-1527. Epub 2020 Jun 24.
3
The effect of sample size on polygenic hazard models for prostate cancer.
Eur J Hum Genet. 2020 Oct;28(10):1467-1475. doi: 10.1038/s41431-020-0664-2. Epub 2020 Jun 8.
4
Age dependence of modern clinical risk groups for localized prostate cancer-A population-based study.
Cancer. 2020 Apr 15;126(8):1691-1699. doi: 10.1002/cncr.32702. Epub 2020 Jan 3.
5
Analysis of polygenic risk score usage and performance in diverse human populations.
Nat Commun. 2019 Jul 25;10(1):3328. doi: 10.1038/s41467-019-11112-0.
6
Clinical use of current polygenic risk scores may exacerbate health disparities.
Nat Genet. 2019 Apr;51(4):584-591. doi: 10.1038/s41588-019-0379-x. Epub 2019 Mar 29.
7
Radical Prostatectomy or Watchful Waiting in Prostate Cancer - 29-Year Follow-up.
N Engl J Med. 2018 Dec 13;379(24):2319-2329. doi: 10.1056/NEJMoa1807801.
8
Germline Genetics of Prostate Cancer: Time to Incorporate Genetics into Early Detection Tools.
Clin Chem. 2019 Jan;65(1):74-79. doi: 10.1373/clinchem.2018.286658. Epub 2018 Nov 20.
9
Generalizing polygenic risk scores from Europeans to Hispanics/Latinos.
Genet Epidemiol. 2019 Feb;43(1):50-62. doi: 10.1002/gepi.22166. Epub 2018 Oct 15.
10
Comparison of Genetic and Self-Identified Ancestry in Modeling Intracerebral Hemorrhage Risk.
Front Neurol. 2018 Jul 6;9:514. doi: 10.3389/fneur.2018.00514. eCollection 2018.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验